IPP Bureau
Merck and Orion collaborate for the development and commercialization of ODM-208
By IPP Bureau - July 16, 2022
Orion to receive an upfront payment of USD 290 million
UPS Healthcare revolutionizes prioritized shipping with UPS Premier
By IPP Bureau - July 16, 2022
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Cellutions BioStorage, a research-to-launch Cryopreservation Bank, inaugurated
By IPP Bureau - July 16, 2022
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
India Health Link join hands with Canopi
By IPP Bureau - July 16, 2022
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network
By IPP Bureau - July 16, 2022
Mittal will be driving expansion of the provider network across India
Enveda appoints Vanitha Sekar as Chief Business Officer
By IPP Bureau - July 16, 2022
She joins Enveda from Gilead Sciences
Enveric Biosciences advances drug development for mental health indications
By IPP Bureau - July 16, 2022
Advancing to IND-enabling studies with multiple drug candidates
Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
By IPP Bureau - July 15, 2022
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene signs 10-year biologics manufacturing agreement with Zoetis
By IPP Bureau - July 15, 2022
Syngene's collaboration with Zoetis started in 2011
Healthcare Triangle closes $6.5 million private placement
By IPP Bureau - July 15, 2022
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Cipla Health signs agreement to acquire Endura Mass
By IPP Bureau - July 15, 2022
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
By IPP Bureau - July 15, 2022
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax statement on EMA Nuvaxovid label update related to allergic reaction
By IPP Bureau - July 15, 2022
Novavax’ clinical development program reported no severe allergic reactions
U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine
By IPP Bureau - July 15, 2022
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Philips highlights AI-powered precision diagnosis portfolio at ECR 2022
By IPP Bureau - July 15, 2022
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
